Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Combining existing strategies could prevent nearly half of new extensively drug-resistant tuberculosis cases

26.10.2007
A synergistic combination of available nosocomial* infection control strategies could prevent nearly half of extensively drug-resistant** (XDR) tuberculosis cases, even in resource-limited settings. These are the conclusions of authors of an Article in this week’s edition of The Lancet.

XDR tuberculosis has been reported in 37 countries (as of May 2007), and has been identified in all regions of the world. South Africa has had the largest cluster of XDR cases, with incidence in every region of the country. Over 200 cases have been reported from 40 sites in the KwaZulu-Natal province alone, the first 53 of which were in the rural town of Tugela Ferry.

Sanjay Basu, Yale University School of Medicine, New Haven, CT, USA, and colleagues combined computer modelling with data from a multi-year epidemiological study to investigate the effect of administrative, environmental ,and personal infection control measures on the epidemic trajectory of XDR tuberculosis in Tugela Ferry. The model simulated inpatient airborne tuberculosis infection, community tuberculosis transmission, and the effect of HIV and anti-retroviral therapy. The model was found to be more than 95% accurate at estimating the course of the disease when evaluated against the latest data from South Africa.

They found that in no new interventions are introduced, around 1300 cases of XDR tuberculosis could occur in the Tugela Ferry area by 2012, more than half are which are likely to be transmitted within the hospital. Use of masks alone would prevent fewer than 10% of cases in the general epidemic, but could, vitally, prevent a large proportion of cases in hospital staff. Combined use of masks, reduced hospitalisation time and a shift to outpatient therphy could prevent nearly a third of cases; and combining this approach with improved ventilation, rapid drug resistance testing, HIV treatment, and tuberculosis isolation facilities could avert nearly half (48%) of cases.

However, the authors add that lengthy hospitalisation or involuntary detention in the absence of sufficient isolation facilities could actually increase the incidence of XDR tuberculosis, since the increased risk of nosocomial transmission outweighed the impact of decreased community-based transmission resulting from these policies.

They conclude by saying their current projections highlight the need for immediate action in addressing the XDR tuberculosis epidemic. The burden of XDR tuberculosis on the health system is already high in this area, and is expected to rise substantially over the next few years.

They say: “Effective hospital-based strategies to limit the transmission of XDR tuberculosis are within reach, even in resource-limited settings…such comprehensive programmes should be rapidly implemented throughout KwaZulu-Natal and the rest of South Africa. Addition community-based strategies should also be developed in parallel, since hospital-based efforts alone might not fully curtail XDR tuberculosis transmission.”

In an accompanying Comment, Dr Travis Porco, University of California, San Francisco, CA, USA, and Dr Wayne Getz, University of California, Berkeley, CA, USA, say: “Multidrug and extensive drug resistance are monsters of our own creation. They might be with us longer than we think and might need us to spend more than governments or institutions are willing or able to pay. Although scientific warnings are often ignored until too late, effective interventions for the control of XDR tuberculosis in Africa are national and international responsibilities, and the world community ignores this message at great peril.”

*Nosocomial infections are those which are contracted as result of a patients treatment in a hospital or healthcare service unit, but secondary to the patients original condition.

**XDR tuberculosis is defined as tuberculosis which is resitant to isoniazid, rifampicin, any fluoroquinolone, and at least one of three injectable second-line drugs (ie. amikacin, kanamycin, or capreomycin).

Tony Kirby | alfa
Further information:
http://multimedia.thelancet.com/pdf/press/Tuberculosis.pdf

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>